Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder

• Published in: BJU international Vol. 106; no. 2; pp. 268 - 274
• Main Authors: Andersson, Karl‐Erik, Sarawate, Chaitanya, Kahler, Kristijan H., Stanley, Elizabeth L., Kulkarni, Amit S.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.07.2010; Wiley-Blackwell
• Subjects: Aged; antimuscarinic; Biological and medical sciences; cardiovascular comorbidities; Cardiovascular Diseases - chemically induced; Cardiovascular Diseases - epidemiology; Epidemiologic Methods; Female; Heart Rate - drug effects; Humans; Male; Medical sciences; Middle Aged; Muscarinic Antagonists - adverse effects; Muscarinic Antagonists - therapeutic use; Nephrology. Urinary tract diseases; OAB; overactive bladder; United States - epidemiology; Urinary Bladder, Overactive - drug therapy; Urinary Bladder, Overactive - epidemiology; Urinary system involvement in other diseases. Miscellaneous; Urinary tract. Prostate gland; United States; Human; Nephrology; Urinary system disease; Cardiovascular disease; Urinary tract disease; Urology; Heart rate; OAB; Concomitant disease; cardiovascular comorbidities; antimuscarinic; Overactive bladder; Bladder disease; Circulatory system

Study Type – Symptom prevalence (retrospective cohort)
Level of Evidence 2b OBJECTIVE To determine if cardiovascular (CV) comorbidity and treatment‐associated antimuscarinic effects differ between patients with and without overactive bladder (OAB), and between treated and untreated patients with OAB...